Article Sidebar
Views pdf: 72
EVALUATION OF TREATMENT OUTCOMES FOR HIGH MYOPIA WITH PHAKIC ICL SURGERY AT SAIGON - CAN THO EYE HOSPITAL
Main Article Content
Abstract
Objective: This study aims to describe the clinical and subclinical characteristics of patients with high myopia and to evaluate the outcomes after 3 months of treatment with Phakic ICL surgery at Saigon - Can Tho Eye Hospital. Subjects and Methods: A prospective descriptive study was conducted on 174 eyes of 87 patients with high myopia who underwent Phakic ICL (EVO/EVO+ Visian ICL) implantation from June 2024 to April 2025. Patients were followed up at 1 day, 1 week, 1 month, and 3 months postoperatively. Indices of efficacy (visual acuity, residual refraction), safety (safety index, vault, intraocular pressure, endothelial cell density), and patient satisfaction were evaluated. Results: The mean age of the patients was 27.0±5.3 years. The mean preoperative spherical equivalent (SE) was -8.7±2.2D. After 3 months, the mean uncorrected distance visual acuity (UDVA) improved from 1.34±0.25 logMAR to 0.03±0.05 logMAR. 98.3% of eyes achieved a UDVA of ≥8/10. The mean residual refraction was 0.01±0.5 D, with 97.8% of eyes within ±1.0D of the target. Regarding safety, the safety index was ≥1.0 in 97.1% of eyes; the mean vault was 512.0±9.3 μm; the endothelial cell loss rate after 3 months was 2.0%. No intraoperative or severe postoperative complications were recorded. The patient satisfaction level was very high, with 97.7% being satisfied or very satisfied. Conclusion: Phakic ICL surgery is a highly effective, safe, and precise treatment method for high myopia. This method provides a high level of patient satisfaction.
Article Details
Keywords
Phakic ICL, high myopia, treatment outcomes, safety, satisfaction
References
2. Trần Tất Thắng, Nguyễn Sa Huỳnh, Nguyễn Thị Thủy Quỳnh, (2024), “Tỷ lệ cận thị và một số yếu tố liên quan đến tỷ lệ cận thị ở học sinh tiểu học tại thành phố Vinh tỉnh Nghệ An”, Tạp Chí Y học Việt Nam, 535(2), tr. 328-331.
3. Alfonso-Bartolozzi B., Fernández-Vega-Cueto L., Lisa C., et al. (2024), “Ten-Year Follow-up of Posterior Chamber Phakic Intraocular Lens With Central Port Design in Patients With Low and Normal Vault”, Journal of Refractive Surgery, 40(3), pp. 159-166.
4. Zaldivar R., Zaldivar R. Jr, Gordillo C.H., Adamek P., (2023), “Visual Acuity Improvement in Low, Moderate and High Myopia After Posterior-Chamber Phakic Implantable Collamer Lens Surgery in a Large Patient Cohort”, Clinical Ophthalmology, pp. 1179-1185.
5. Chen X., Li L., Rao J., et al. (2023), “Long-term observation on safety and visual quality of implantable collamer lens V4c implantation for myopia correction: a 5-year follow-up”, International Journal of Ophthalmology, 16(7), pp. 1123-1129.
6. Lwowski C., Van Keer K., Ruscher T. et al. (2023), “Five-year follow-up of a posterior chamber phakic intraocular lens with a central hole for correction of myopia”, Int Ophthalmol 43, pp. 4933-4943.
7. Kamiya K., Shimizu K., Takahashi M., et al. (2021). Eight-year outcomes of implantation of posterior chamber phakic intraocular lens with a central port for moderate to high ametropia. Frontiers in Medicine, 8, 799078.
8. Chen X., Wang X., Xu Y., et al. (2021). Five-year outcomes of EVO implantable collamer lens implantation for the correction of high myopia and super high myopia. Eye and Vision, 8(1), 40.
9. Packer M. (2018), “The Implantable Collamer Lens with a central port: review of the literature”, Clin Ophthalmol, 12, pp. 2427-2438.